Chargement en cours...
In Vitro and In Vivo Antibacterial Activities of CS-834, a New Oral Carbapenem
CS-834 is a prodrug of the carbapenem R-95867, developed by Sankyo Co., Ltd., Tokyo, Japan. To investigate the possibility that CS-834 may be the first carbapenem usable in an oral dosage form, its in vitro antibacterial activity (as R-95867) and in vivo antibacterial activity were compared with tho...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
1998
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC105498/ https://ncbi.nlm.nih.gov/pubmed/9517932 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|